{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:46:58Z","timestamp":1767134818793,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd000239","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T00:00:00Z","timestamp":1409788800000}}],"reference-count":62,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000239.pub2","type":"journal-article","created":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T23:22:36Z","timestamp":1409872956000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients"],"prefix":"10.1002","volume":"2017","author":[{"given":"Helle Krogh","family":"Johansen","sequence":"first","affiliation":[{"name":"Rigshospitalet; The Nordic Cochrane Centre; Blegdamsvej 9, 3343 Copenhagen Denmark DK 2100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C","family":"G\u00f8tzsche","sequence":"additional","affiliation":[{"name":"Rigshospitalet; Nordic Cochrane Centre; Blegdamsvej 9, 7811 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,9,4]]},"reference":[{"key":"10.1002\/14651858.CD000239.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1439-0507.1993.tb00725.x","article-title":"Fluconazole versus oral amphotericin B in preventing fungal infection in chemotherapy-induced neutropenic patients with haematological malignancies","volume":"36","author":"Akiyama","year":"1993","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/clinids\/23.5.964","article-title":"Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature","volume":"23","author":"Anaissie","year":"1996","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/1097-0142(19940415)73:8<2099::AID-CNCR2820730814>3.0.CO;2-N","article-title":"Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B","volume":"73","author":"Bodey","year":"1994","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD000239.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ajh.10234","article-title":"Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation","volume":"71","author":"Koh","year":"2002","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0005|cit5","unstructured":"Lake D Kunzweiler J A randomized trial of fluconazole vs. amphotericin B for the treatment of esophageal candidiasis in the adult cancer patient Proceedings of the Annual Meeting of American Society for Clinical Oncology 1991 344 (abstract 1222)"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000239459","article-title":"Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients","volume":"42","author":"Lake","year":"1996","journal-title":"Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD000239.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0002-9343(98)00326-X","article-title":"A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia","volume":"105","author":"Malik","year":"1998","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0008|cit8","unstructured":"Lapierre V Marie J-P Pico JL Molina A Andremont A Lagrange P Intravenous fluconazole (Flu) versus intravenous amphotericin B (AmB) in the management of febrile neutropenic patients: a multicentric randomized study 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, October 1992, Anaheim, California 1992 214 (abstract 624)"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0009|cit9","first-page":"171","article-title":"Etude multicentrique randomis\u00e9e fluconazole iv versus amphot\u00e9ricine B iv chez le patient neutrop\u00e9nique et f\u00e9brile","volume":"2","author":"Marie","year":"1993","journal-title":"Cahiers d'Oncologie"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0010|cit10","unstructured":"Viscoli C European studies of fluconazole (F) vs amphotericin B (AmB) in febrile neutropenic cancer patients 7th European Congress of Clinical Microbiology and Infectious Diseases, March 26 to March 30, 1995, Vienna, Austria 1995 14 (abstract 70)"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-120-11-199406010-00003","article-title":"Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. The GIMEMA Infection Program","volume":"120","author":"Menichetti","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF03259575","article-title":"Chemoprophylaxis of fungal infections in granulocytopenic patients using fluconazole vs oral amphotericin B","volume":"3","author":"Meunier","year":"1991","journal-title":"Drug Investigation"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jac\/40.6.855","article-title":"Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer","volume":"40","author":"Groll","year":"1997","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF01974614","article-title":"A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group","volume":"13","author":"Ninane","year":"1994","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/978-3-642-74643-7_97","article-title":"Management of fungal infection in neutropenic patients with fluconazole","volume":"33","author":"Brammer","year":"1990","journal-title":"Haematology and Blood Transfusion"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/myc.1990.33.1s.42","article-title":"[Comparison of oral fluconazole and amphotericin B prophylaxis against fungal infections in the neutropenic phase of patients treated with antileukemic agents]","volume":"33 Suppl 1","author":"Finke","year":"1990","journal-title":"Mycoses"},{"issue":"6","key":"10.1002\/14651858.CD000239.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/31.6.973","article-title":"Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group","volume":"31","author":"Philpott-Howard","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD000239.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jac\/27.3.369","article-title":"A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia","volume":"27","author":"Rozenberg-Arska","year":"1991","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0019|cit19","first-page":"A120, abstract","article-title":"Oral fluconazole (F) vs oral polyenes (P) as antimycotic prophylaxis in neutropenia: an European multicenter study","volume":"65","author":"Schuler","year":"1992","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0020|cit20","first-page":"27 (abstract)","article-title":"Fluconazole versus polyenes as oral anti-fungal prophylaxis in autologous and allogeneic bone marrow recipients","volume":"4 Suppl 2","author":"Milliken","year":"1989","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0021|cit21","first-page":"135, abstract 2","article-title":"Antifungal prophylaxis with fluconazole in bone marrow transplants","volume":"5 Suppl 2","author":"Powles","year":"1990","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1439-0507.1999.tb00023.x","article-title":"Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B\/flucytosine","volume":"42 Suppl 2","author":"Silling","year":"1999","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0023|cit23","first-page":"159","article-title":"Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B\/5-fluorocytosine","volume":"42(3)","author":"Silling","year":"1999","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0024|cit24","first-page":"S2, abstract 8","article-title":"Early empiric antifungal therapy of infections in neutropenic patients with hematologic malignancies: fluconazole vs ampho B\/5-FC","volume":"78 Suppl 1","author":"Silling","year":"1999","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0025|cit25","first-page":"A101, abstract","article-title":"Fluconazole (FCA) versus amphotericin B\/5-flucytosine (ABF) for the treatment of febrile neutropenia","volume":"70 Suppl 1","author":"Silling","year":"1995","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0026|cit26","first-page":"306a","article-title":"Early empiric antifungal treatment of infections in neutropenic patients comparing fluconazole with amphotericin B\/5-flucytosine","volume":"10 Suppl 1","author":"Silling-Engelhardt","year":"1994","journal-title":"Blood"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0027|cit27","first-page":"A110, abstract","article-title":"Interventional treatment of unexplained fever (FUO) and documented infections in neutropenic patients with hematologic malignancies: fluconazole versus ampho B\/5-FC","volume":"64","author":"Silling-Engelhardt","year":"1992","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0028|cit28","first-page":"535","article-title":"A randomised study to compare oral fluconazole with oral amphotericin B for suppression of fungal flora and prevention of fungal infection in bone marrow transplantation recipients","volume":"7","author":"Teshima","year":"1994","journal-title":"Drug Evaluation (Konnichi No Ishoku)"},{"issue":"5","key":"10.1002\/14651858.CD000239.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0959-8049(95)00619-2","article-title":"Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial","volume":"32A","author":"Viscoli","year":"1996","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0030|cit30","unstructured":"Winston DJ Hathorn J Schuster M Fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients: results of a randomised multicenter trial 20th International Congress of Chemotherapy, June 29 to July 3, 1997, Sydney, Australia 1997 87 (abstract 3243)"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0031|cit31","unstructured":"Winston DJ Hathorn J Schuster M Fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients: results of a randomized multi-center trial 10th International Symposium on Infections in the Immunocomprised Host, June 21-24, 1998, Davos, Switzerland 1998 abstract no 112"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0002-9343(99)00457-X","article-title":"A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer","volume":"108","author":"Winston","year":"2000","journal-title":"American Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD000239.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bmt.1702233","article-title":"Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group","volume":"25","author":"Wolff","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0163-4453(95)80009-3","article-title":"Systemic amphotericin B versus fluconazole in the management of antibiotic resistant neutropenic fever - preliminary observations from a pilot, exploratory study","volume":"30","author":"Ellis","year":"1995","journal-title":"Journal of Infection"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0035|cit35","unstructured":"Reed E Rasmussen J Roberson P Armitage J Bierman P Vose J Interim analysis of fluconazole (flu), intermittent amphotericin (ampho) and no treatment (ntx) for prophylaxis of fungal disease in bone marrow transplant (BMT) and acute leukemia (AL) patients (pts) Proceedings of the Annual Meeting of American Society for Clinical Oncology 1993 465 (abstract A1622)"},{"issue":"8","key":"10.1002\/14651858.CD000239.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bmt.1702243","article-title":"Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial","volume":"25","author":"Timmers","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00005792-197405000-00004","article-title":"Effect of prophylactic measures on the microbial flora of patients in protected environment units","volume":"53","author":"Bodey","year":"1974","journal-title":"Medicine"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Bow EJ Laverdiere M Lussier N Rotstein C Ioannou S Antifungal prophylaxis in neutropenic cancer patients - a meta-analysis 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 28 to October 1, 1997, Toronto, Ontario, Canada 1997 abstract no LM-88","DOI":"10.1016\/S1368-7646(98)80218-5"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/cncr.10610","article-title":"Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials","volume":"94","author":"Bow","year":"2002","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2288-6-40","article-title":"Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents","volume":"6","author":"Due","year":"2006","journal-title":"BioMed Central Medical Research Methodology"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/AAC.36.1.172","article-title":"Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B","volume":"36","author":"Ellis","year":"1992","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"7286","key":"10.1002\/14651858.CD000239.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bmj.322.7286.579","article-title":"Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial","volume":"322","author":"Eriksson","year":"2001","journal-title":"BMJ"},{"issue":"13","key":"10.1002\/14651858.CD000239.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jac\/40.6.855","article-title":"Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer","volume":"40","author":"Groll","year":"1997","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bmj.314.7089.1238","article-title":"Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia","volume":"314","author":"G\u00f8tzsche","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD000239.pub2-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000026","article-title":"Routine versus selective antifungal administration for control of fungal infections in patients with cancer","author":"G\u00f8tzsche","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD000239.pub2-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002033","article-title":"Nystatin prophylaxis and treatment in severely immunodepressed patients","author":"G\u00f8tzsche","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6217","key":"10.1002\/14651858.CD000239.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.280.6217.833","article-title":"Study of information submitted by drug companies to licensing authorities","volume":"280","author":"Hemminki","year":"1980","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0049|cit49","doi-asserted-by":"crossref","unstructured":"Johansen HK G\u00f8tzsche PC Systematic reviews of prophylactic or empirical antifungal therapy in cancer patients with neutropenia 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 28 to October 1, 1997, Toronto, Ontario, Canada 1997 abstract no LM-89","DOI":"10.1016\/S1368-7646(98)80218-5"},{"issue":"1","key":"10.1002\/14651858.CD000239.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s005200050224","article-title":"Must we really fear toxicity of conventional amphotericin B in oncological patients?","volume":"7","author":"Mayer","year":"1999","journal-title":"Support Care Cancer"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/bmj.306.6885.1125-b","article-title":"Effective and acceptable treatment for depression (letter)","volume":"306","author":"Nakielny","year":"1993","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD000239.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1128\/AAC.43.6.1417","article-title":"Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion","volume":"43","author":"Nath","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1002\/14651858.CD000239.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/bmj.316.7126.221","article-title":"Unresolved issues and future developments","volume":"316","author":"Smith","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/bmj.306.6879.683","article-title":"Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability","volume":"306","author":"Song","year":"1993","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/bmj.315.7109.640","article-title":"Publication bias: evidence of delayed publication in a cohort study of clinical research projects","volume":"315","author":"Stern","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0057|cit57","first-page":"177","article-title":"Candida infections in bone marrow transplant recipients","volume":"8","author":"Verfaillie","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0959-8049(94)90412-X","article-title":"Factors associated with bacteraemia in febrile, granulocytopenic cancer patients","volume":"30A","author":"Viscoli","year":"1994","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jac\/36.6.899","article-title":"Antifungal drug chemotherapy. Antifungal drug susceptibility testing","volume":"36","author":"Working Party of the British Society for Antimicrobial Chemotherapy","year":"1995","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD000239.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jama.282.18.1752","article-title":"Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis","volume":"282","author":"Johansen","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD000239.pub2-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000239","article-title":"Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients","author":"Johansen","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000239.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000239","article-title":"Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients","author":"Johansen","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000239.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T03:17:39Z","timestamp":1682565459000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000239.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,4]]},"references-count":62,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000239.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,4]]}}}